- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Cyclacel Pharmaceuticals Inc+ Add to Watchlist
CYCC:US3.2800 USD 0.1100 3.47%
As of 20:10:00 ET on 04/17/2014.
Company Profile for Cyclacel Pharmaceuticals Inc (CYCC)
Cyclacel Pharmaceuticals Inc. discovers and develops small molecule cycle inhibitors for the treatment of cancer and other serious diseases.
Cyclacel Pharmaceuticals Inc
Key Executives for Cyclacel Pharmaceuticals Inc (CYCC)
|Spiro G RombotisPresident/CEO||Paul McBarronExec VP:Finance/CFO/COO/Secy|
|Judy ChiaoVP:Clinical Dev & Reg Affairs|